Triple
T23650490
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Kymriah |
E584153
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | oncology drug |
C27669
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: oncology drug Context triple: [Kymriah, instanceOf, oncology drug]
-
A.
cancer drug
A cancer drug is a therapeutic agent specifically designed to prevent, slow, or eliminate the growth and spread of cancer cells in the body.
-
B.
CDK4/6 inhibitor
A CDK4/6 inhibitor is a targeted anticancer drug that blocks cyclin-dependent kinases 4 and 6 to halt cell cycle progression from G1 to S phase, thereby inhibiting tumor cell proliferation.
-
C.
PARP inhibitor
A PARP inhibitor is a targeted anticancer drug that blocks poly(ADP-ribose) polymerase enzymes to prevent DNA repair in tumor cells, leading to their death, particularly in cancers with existing DNA repair defects such as BRCA-mutated tumors.
-
D.
immunomodulatory drug
chosen
An immunomodulatory drug is a pharmacological agent that alters the immune system’s activity—either enhancing or suppressing immune responses—to treat diseases such as autoimmune disorders, cancers, or inflammatory conditions.
-
E.
cancer
Cancer is a class of diseases characterized by uncontrolled cell growth and division, often leading to the formation of tumors and potential spread to other parts of the body.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e248fefafc81909656921192f30e80 |
completed | April 17, 2026, 2:51 p.m. |
Created at: April 17, 2026, 6:49 p.m.